Furthermore, we also sought the correlations between the expression of NAP1L1 and the HCC patients’ clinical features from age (Figure 4C, Supplementary Figures S1C,S2C, S3C), gender (Figure 4D, Supplementary Figures S1D,S2D, S3D), and stage (Figure 4E, Supplementary Figures S1E,S2E, S3E). The gene discussed is NAP1L1; the disease is hepatocellular carcinoma.